SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as it breaks multi-year highs, with the community actively discussing its potential as 'the better Bitcoin' due to its privacy features and limited supply. Some believe influencers are promoting ZEC, contributing to strong buying pressure, while others anticipate a continued run towards significantly higher prices and compare it to Bitcoin's early days. The upcoming halving event is also fueling excitement.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending as traders focus on its low float and potential for a significant price surge. Community discussions highlight the stock's recent momentum and anticipation for a breakout, with some comparing it to other low-float runners like $HKD. The stock's technical setup and recent volume suggest a potential squeeze, attracting both day traders and those looking for multi-day gains.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending due to a potential bidding war with Novo Nordisk for Metsera, a company developing obesity drugs, after Novo Nordisk made a higher bid. The community is discussing the implications of this deal, including potential antitrust issues, and whether Pfizer will counter or pursue alternative acquisitions like Viking Therapeutics. Some investors express frustration with Pfizer's stock performance despite positive news, focusing on its dividend yield and potential for a turnaround.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FCEL is trending amid growing interest in fuel cell technology for clean energy and AI data centers, with community members drawing comparisons to $BE's recent surge. Discussions revolve around potential catalysts, like new contracts and partnerships, and the possibility of a short squeeze given the stock's low float and increasing volume. Some investors express concern over past performance and dilution, while others highlight the company's potential in the evolving energy landscape.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is trending as investors react to news of a SEC probe into competitor AppLovin's data practices, with some viewing this as a potential catalyst for Unity to capture market share in the mobile advertising space.  The community is discussing the possibility of a rotation from $APP to $U, and the potential for Unity's Vector AI platform to gain prominence.  Additionally, Wedbush reiterated their $42 price target with positive phrasing.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending despite a recent drop attributed to concerns raised by an FDA official, causing uncertainty among investors. The community is debating the validity of these concerns and the company's response, while some speculate about underlying motives and potential impacts on future drug approvals. Discussions also involve potential buyback and takeover scenarios.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

ZVRA is trending as rumors of potential acquisition swirl, with the community buzzing about a potential buyout after reports of a failed financing attempt from a smaller company.  Enthusiasm is building for the upcoming earnings report and the potential for a positive outcome, while some investors express skepticism toward management. Bullish sentiment is further fueled by high short interest, leading to speculation about a possible short squeeze.

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.

Metsera Inc.

Metsera Inc

MTSR is trending due to a potential bidding war between Novo Nordisk and Pfizer to acquire the company, with Novo Nordisk submitting a higher offer, leading to community discussion around the fairness of the deals and potential outcomes. The community speculates about Pfizer potentially countering the offer and if other companies may enter the bidding war. There's also chatter around how the bidding war may impact other companies in the obesity space, such as Viking Therapeutics.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is trending due to renewed optimism in the solar sector and positive sentiment around its energy storage potential, highlighted by a significant contract win. Community members are actively discussing the possibility of a short squeeze given the high short interest, while others point to the valuation gap between CSIQ and its subsidiary, CSI Solar, as a reason for potential upside.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB Inc is trending as the community discusses its recent price action and potential breakout, while some analysts suggest the stock is overvalued. Discussions include analysis of insider selling and revenue growth in relation to competitor valuations. Technical analysis of the stock's chart patterns, along with speculation about future price movements, are also circulating.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Enter:  $BMNR Calls
Strike Price: $46
Expiry Date: NOV 21 2025 

Buy in Price: $3.50 - $3.68
Sell Price: $6.54
Profit : +87% (Turn every $1 into $1.87)

Want Profitable Real-Time Options Alerts? 
👉 https://moneygroup.us

Moneygroup

Money Group

StockTwits Web

Bitmine Immersion Technologies Inc

 Calls
Strike Price: $46
Expiry Date: NOV 21 2025 

Buy in Price: $3.50 - $3.68
Sell Price: $6.54
Profit : +87% (Turn every $1 into $1.87)

Want Profitable Real-Time Options Alerts? 
👉 